Early Baldness Increases Odds of Prostate Cancer for African Americans

This article originally appeared here.
Share this content:
Early Baldness Ups Prostate CA Risk for African-Americans
Early Baldness Ups Prostate CA Risk for African-Americans

(HealthDay News) -- For African-Americans, who are at elevated prostate cancer risk, baldness at age 30 correlates with prostate cancer, with frontal baldness linked to increased odds of high-stage and high-grade disease, according to a study published online March 26 in Cancer Epidemiology, Biomarkers & Prevention.

Charnita Zeigler-Johnson, Ph.D., from the University of Pennsylvania School of Medicine in Philadelphia, and colleagues recruited 318 African-American prostate cancer cases and 219 African-American controls to examine the correlation between early-onset baldness with prostate cancer.

The researchers found that baldness correlated with increased likelihood of prostate cancer (odds ratio [OR], 1.69). Frontal baldness correlated with increased odds of high-stage (OR, 2.61) and high-grade (OR, 2.20) tumors, with a stronger correlation for men diagnosed before the age of 60 years (OR, 6.51 and 4.23, respectively). There was a suggested interaction for smoking, median age, and any baldness.

"African-American men present with unique risk factors including baldness patterns that may contribute to prostate cancer disparities," the authors write.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs